News Stories

Medtronic receives FDA approval for smallest defibrillation lead of its kind

Medtronic has received U.S. FDA approval for its OmniaSecure defibrillation lead for placement within a patient’s right ventricle. The lead is delivered through the use of a catheter and connects to an implantable defibrillator to help treat ventricular tachyarrhythmias, ventricular fibrillation or bradyarrhythmias in patients 12 years old and older.

FDA approves leadless CRT device for heart failure

EBR Systems has gained U.S. FDA approval for its innovative wireless pacing device for heart failure, the WiSE cardiac resynchronization therapy (CRT) system. The device works with a patient’s existing implant to provide biventricular pacing.

FDA approves leadless CRT device for heart failure

The WiSE cardiac resynchronization therapy (CRT) system. The device works with a patient’s existing implant to provide biventricular pacing.

Post-TAVI Pacemaker Tied to Poorer Long-term Outcomes

Whether newer pacing techniques can mitigate death, LV decline, and HF symptoms in TAVI patients remains to be seen.

Chronic HF Patients Needing CRT Fare Better With LBB Pacing: HeartSync-LBBP

Despite the randomized trial showing a difference in outcomes, more data are needed before changing practice, says one expert.